Settling the thymus: immigration requirements. by Cyster, Jason G
UCSF
UC San Francisco Previously Published Works
Title
Settling the thymus: immigration requirements.
Permalink
https://escholarship.org/uc/item/5j055338
Journal
The Journal of experimental medicine, 206(4)
ISSN
0022-1007
Author
Cyster, Jason G
Publication Date
2009-04-06
DOI
10.1084/jem.20090458
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
731
COMMENTARY
The Rockefeller University Press $30.00
J. Exp. Med. Vol. 206 No. 4 731-734
www.jem.org/cgi/doi/10.1084/jem.20090458
To support sustained T cell produc-
tion, the thymus depends on a supply 
of thymic progenitor cells (TPCs) ar-
riving via the blood. TPCs settle the 
thymus in waves separated by multiple 
weeks (1). This has led to the fascinat-
ing concept that precursor immigration 
to the thymus is “gated.” One clue to 
how thymic gating occurs came from 
the finding that mice lacking IL-7R, 
which have dramatically reduced cell 
numbers in the thymus, had a marked 
increase in receptivity for settling by 
transferred precursors (2). Thus, gate 
opening is promoted when TPC num-
bers are low. But how gate opening is 
regulated remains a mystery. On page 
761 of this issue, Gossens et al. (3) 
report on important new findings 
that identify additional factors that in-
fluence thymic gating and precursor 
immigration.
Immigration requirements: P-selectin 
ligand and CCR9
It is estimated that as few as 10 TPCs 
settle the mouse thymus per day (4). 
These cells give rise to early thymic 
progenitors (ETPs; characterized as 
LinCD44+CD25CD117+ cells) that 
progress though the CD4 and CD8 
double-negative (DN) stages (DN2, 
DN3, and DN4) of development over 
a period of 2 wk before becoming 
double-positive (DP) cells and, eventu-
ally, CD4 or CD8 single-positive (SP) 
T cells (4). Recent studies have shown 
that both P-selectin and CCR9 are re-
quired for TPCs to enter the thymus 
(4). Mice lacking these molecules have 
fewer immature cells in the thymus, yet 
generate normal numbers of DP and SP 
thymocytes, suggesting that additional 
undefined molecules also mediate TPC 
homing. P-selectin is expressed by thy-
mic vessels (5), most likely in venules 
(6), and P-selectin glycoprotein ligand-
1 (PSGL-1) is its only defined ligand. 
The P-selectin binding site on PSGL-1 
is made up in part by core-2-O–linked 
sugars (7), and cells deficient in core 
2 b1,6-glucosaminyltransferase-I (C2) 
suffer a partial impairment in P-selec-
tin–dependent rolling (7). The CCR9 
ligand CCL25 (TECK) is expressed by 
thymic endothelial cells and medul-
lary and cortical epithelial cells (3, 8). 
Although the phenotype of TPCs re-
mains a matter of debate, the emerg-
ing consensus is that they express both 
PSGL-1 and CCR9 (4, 9).
Periodicity in P-selectin  
and CCL25 expression
The study by Gossens et al. (3) begins 
with the authors’ previous finding that 
IL-7R–deficient mice have elevated P-
selectin expression on thymic vessels 
(5). To further explore the correlation 
between niche occupancy and expres-
sion of molecules needed for TPC 
homing, the authors examined mice 
deficient in P-selectin, PSGL-1, and 
C2. Using intrathymic injection of 
bone marrow cells to measure niche 
occupancy, they find that all three 
strains have increased availability of 
thymic niche space (3). Findings in IL-
7R/ mice suggested that DN3 num-
bers controlled niche availability (2), 
but no alterations in DN3 numbers 
were seen in the three trafficking mu-
tants in this study. Instead, there was a 
correlation between receptivity and 
endogenous ETP numbers in the thy-
mus. Thus, the number of ETPs (or a 
subset within this compartment) may 
control intrathymic niche availability 
for incoming thymic precursors.
Supporting a positive relationship 
between niche occupancy and P-selec-
tin expression, PSGL-1/ mice had 
increased levels of P-selectin transcripts 
and protein, approaching the levels 
seen in IL-7R/ mice. Unexpectedly, 
however, C2-deficient mice showed 
minimal increases in P-selectin (3). A 
second thymic homing factor, CCL25, 
was also increased in IL-7R– and 
PSGL-1–deficient (but not C2-defi-
cient) thymi. In short-term homing as-
says with wild-type cells, homing to 
the thymus was increased in PSGL-
1/ recipients, but was not apprecia-
bly increased in C2/ recipients, 
which is congruent with the P-selectin 
and CCL25 expression data. Thus, the 
relationship between thymic progeni-
tor niche occupancy and endothelial 
homing molecule expression seemed 
to hold up for PSGL-1–deficient mice, 
but not for C2-deficient mice.
With two thymic homing mole-
cules apparently responding to niche 
occupancy signals, Gossens et al. asked 
whether the periodicity of thymic 
gating could be associated with a peri-
odicity in homing molecule expres-
sion. Remarkably, P-selectin transcript 
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S1P source have normal thymic egress 
(13). S1P produced by a radiation-resis-
tant source is more potent than RBC-
derived S1P in promoting egress (13), 
and it will be interesting to explore 
whether the former source is affected 
by PSGL-1 deficiency.
Although the significance of the re-
duced plasma S1P in PSGL-1–deficient 
mice is not yet clear, it prompted the 
authors to make a potentially important 
connection. Endothelial cells express 
multiple S1P receptors, and S1P has 
been shown to augment P-selectin ex-
pression in vitro (3, 14). The authors 
pursued this relationship in vivo and 
discovered a correlation between S1P 
plasma abundance and thymic P-selec-
tin mRNA levels in wild-type mice. 
Moreover, 3 d of treatment with the 
S1P agonist FTY720, which blocks 
thymic egress, lead to a reduction in 
P-selectin mRNA levels. P-selectin 
mRNA levels also decreased when S1P 
lyase was inhibited, increasing thymic 
S1P levels to amounts previously shown 
to decrease thymocyte S1P1 expression 
(12). Both of these treatments may 
cause desensitization (or degradation) of 
S1P receptors—perhaps those basolat-
erally exposed on endothelial cells—and 
thus reduce S1P-mediated P-selectin 
induction (Fig. 2). Future studies will 
need to explore the specific S1P recep-
tors involved and whether the action 
is directly on the endothelial cell or 
at another site. Because P-selectin is 
to PSGL-1/ mice, thymic P-selectin 
mRNA levels dropped twofold in 2 d 
and receptivity for thymic settling was 
correspondingly diminished. Recipro-
cally, when peripheral CD4 and CD8 T 
cells were depleted for 24 h in wild-type 
mice, P-selectin expression and precur-
sor receptivity increased. These results 
raise the exciting possibility that thymic 
receptivity for precursors is responsive 
to the peripheral demand for T cells. 
But how do alterations in peripheral T 
cell numbers alter thymic P-selectin ex-
pression? Here, Gossens et al. (3) find 
evidence for an unexpected link be-
tween sphingosine-1-phosphate (S1P) 
and thymic precursor immigration.
The current model for thymic egress 
posits that after SP thymocytes up-reg-
ulate S1P receptor-1 (S1P1), they en-
counter S1P associated with the blood 
vasculature and are triggered to emi-
grate (10). S1P is abundant in the blood 
and is kept low within the thymus by 
the action of S1P lyase (12). Using an 
internally standardized mass spectrome-
try assay, Gossens et al. measured the 
abundance of S1P in the blood and 
found a small but apparently significant 
reduction of S1P (20%) in PSGL-
1/ mice compared with wild-type 
mice—a reduction that is unlikely to 
cause an egress defect. P-selectin–defi-
cient mice, on the other hand, had in-
creased plasma S1P (3). Red blood cells 
(RBCs) are the source of 90% of 
blood S1P, and yet mice lacking this 
abundance oscillated in the adult thy-
mus with a periodicity of 2 wk. 
CCL25 oscillated to a lesser extent, 
perhaps reflecting its more widespread 
expression in the thymus, but a correla-
tion was observed between periods of 
high P-selectin and high CCL25 ex-
pression. These oscillations were less 
evident in PSGL-1– and C2-deficient 
mice, suggesting a negative link be-
tween the extent of niche occupancy 
and the propensity for oscillations to 
occur. Thus, the periodic filling and 
emptying of thymic niches may induce 
a corresponding change in P-selectin 
and CCL25 expression, which rise in 
occurence when the niches are empty 
and new precursors are needed, and 
then fall off once the niches are filled 
(Fig. 1). Future studies will need to 
quantitate ETP numbers in parallel with 
assessment of P-selectin and CCL25 
protein abundance to more definitively 
establish this relationship.
Periphery-thymus cross talk via S1P
The authors next tried to find an expla-
nation for the fact that ETP numbers 
were similarly reduced in PSGL-1/ 
and C2/ mice, despite the larger ele-
vation in homing molecule expression 
in the PSGL-1/ mice. A close look at 
the thymic subsets in PSGL-1/ mice 
revealed an increase in the frequency of 
semimature (also called immature) SP 
cells and mature SP cells. This finding, 
along with the twofold decrease in cir-
culating T cells in the periphery, sug-
gested a possible thymic egress defect. 
SP thymocytes did not accumulate in 
the C2-deficient mice. The accumula-
tion of thymocytes at the semimature 
SP stage is unusual for a thymic egress 
defect, as other strains of mice with 
egress defects selectively accumulate 
mature SP cells (10, 11). However, two 
additional approaches (intrathymic FITC 
injection and T cell receptor excision 
circle analysis) supported the authors’ 
claim that egress is affected.
The authors suspected that the de-
creased number of circulating blood 
cells seen in the PSGL-1–deficient mice 
somehow facilitated the induction of P-
selectin. Indeed, when 20 million lym-
phocytes were intravenously injected in 
Figure 1. Model to explain how niche occupancy by ETPs affects endothelial P-selectin and 
CCL25 expression. When the thymic niche is occupied (left), a signal generated by ETPs or niche 
cells inhibits P-selectin and CCL25 expression by the endothelium. Over a period of 2 wk, some ETP 
niches become vacant, relieving the inhibitory signal and leading to increased P-selectin and CCL25 
expression (right). TPCs are then able to home into the thymus and give rise to ETPs, restarting the 
“clock.” Alternatively, when a niche is empty, niche cells may release a factor that promotes endothe-
lial P-selectin and CCL25 expression and is consumed by ETPs.
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degradation, but this explanation does 
not readily fit with the finding that 
Rag1/ and IL-7R/ mice have 
normal amounts of plasma S1P (3, 13). 
Perhaps lymphocyte transfers and de-
pletion treatments cause fluctuations in 
a cell type or cytokine that in turn 
modulates S1P production or degrada-
tion. Another conundrum is that blood 
S1P is present at micromolar concen-
trations, yet S1P receptors have nano-
molar affinities (19). How could small 
(20–30%) changes in plasma S1P lead 
to alterations in endothelial behavior? 
Most S1P in the blood is bound to 
albumen or HDL and may not be 
bioavailable. Is it possible that the 
bioavailable amounts of plasma S1P 
fluctuate within a meaningful range? 
The finding that S1P1 surface expres-
sion on blood T cells is fully down-
modulated even in mice with 5–10% 
of normal plasma S1P makes this un-
likely (13). Perhaps the S1P elevations 
saturate degradation systems that nor-
mally keep tissue concentrations low, 
and this allows increased access of S1P 
to ablumenally distributed S1P recep-
tors (Fig. 2). Or maybe the changes in 
plasma S1P are indirect readouts of 
more relevant local changes in S1P 
production by radiation-resistant cell 
types (perhaps endothelial cells). 
Clearly, much more work is needed, 
but the study by Gossens et al. (3) 
highlights the need to consider the 
physiological correlates of even small 
changes in plasma S1P.
Finally, we come back to the initial 
puzzle of why PSGL-1 deficiency, but 
not C2 deficiency, causes marked 
elevations in thymic P-selectin ex-
pression. Despite the many studies 
dedicated to this issue, the explanation 
for this discrepancy remains unclear. 
The deficiency in circulating T cells in 
PSGL-1/ mice seems to play a role, 
as transferring in large numbers of 
lymphocytes decreases P-selectin ex-
pression. Perhaps the presence of trans-
ferred PSGL-1+ cells in the mice 
compensates for a missing signal. Cer-
tainly, a variety of experiments can 
now be planned to better define where 
PSGL-1 acts to control thymic P-se-
lectin expression.
opens up many new questions. For ex-
ample, how is the periodic P-selectin 
expression achieved? This study and 
earlier work suggests that maturation of 
the limited pool of ETPs is involved, 
but how niche emptying triggers eleva-
tions in endothelial P-selectin is not yet 
defined. One study showed that Egr1 is 
needed in the ETP to efficiently deliver 
this signal (15). The role of PSGL-1 in 
thymocyte maturation and how it 
affects thymic egress is also unclear. 
PSGL-1 promotes T cell migration to-
ward the CCR7 ligand CCL21 by en-
hancing chemokine binding (16), 
raising the question of whether it mod-
ulates responsiveness to S1P in a similar 
way. And how does PSGL-1 deficiency 
cause a reduction in plasma S1P abun-
dance? This is especially perplexing in 
the context of the finding that periph-
eral lymphocyte depletion was other-
wise associated with an increase in 
plasma S1P. The S1P elevation seen in 
P-selectin–deficient mice may well fit 
with data showing that P-selectin defi-
ciency causes an increase in circulating 
HDL, given that HDL carry plasma S1P 
(17, 18). However, a relationship be-
tween PSGL-1 and HDL has not been 
reported.
Why does lymphocyte transfer re-
duce plasma S1P and lymphocyte de-
pletion increase it? A straightforward 
argument is that lymphocytes are a 
major compartment for plasma S1P 
expressed by venules in most tissues, it 
will be important to determine if its ex-
pression is also modulated in other vas-
cular beds.
Exploring whether alterations in cir-
culating lymphocyte number might in-
fluence thymic P-selectin expression 
by altering S1P abundance, the authors 
found that S1P was elevated in plasma 
of T cell–depleted mice (contrary to 
what happens in the lymphopenic 
PSGL-1/ mice). Reciprocally, when 
T or B cells were infused into PSGL-
1/ mice, the S1P concentration was 
further reduced (3). In these cases, the 
small increases or decreases in plasma 
S1P are concordant with the corre-
sponding changes in thymic P-selectin 
expression (Fig. 2).
Ongoing interrogations at the border
In summary, the study by Gossens et al. 
(3) suggests that oscillating thymic ex-
pression of P-selectin and CCL25 may 
contribute to thymic gating. The new 
data reveal a possible role for PSGL-1 in 
thymic egress and provide evidence for 
an in vivo relationship between plasma 
S1P abundance and thymic P-selectin 
expression. This work not only pro-
vides insights into factors regulating 
thymic precursor immigration, it also 
has implications for understanding the 
interplay between S1P and the vascular 
system. However, the work also leaves 
us with some unresolved issues and 
Figure 2. Model for how changes in plasma S1P affect the expression of P-selectin by 
thymic endothelium. The micromolar concentrations of S1P in plasma may continuously saturate 
luminal S1P receptors (left), but small increases in plasma S1P (or local changes in S1P production 
by endothelial cells) may increase the engagement of receptors on the ablumenal side of the 
enodothelium, where S1P concentrations are low, leading to changes in expression of genes such 
as P-selectin (right).
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The authors leave us with the im-
portant concept that reductions in pe-
ripheral T cell numbers can lead to 
elevations in the expression of thymic 
homing molecules. Future analyses will 
help to determine whether the lym-
phopenia that can occur after viral in-
fection or in other diseases is associated 
with elevations in thymic P-selectin 
and CCL25 expression and receptivity 
for TPCs.
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